Share this postThe Drug Development LetterSpecial ESMO 2024 edition !Copy linkFacebookEmailNotesMorePlayback speed×Share postShare post at current timeShare from 0:000:00/0:00Transcript11Share this postThe Drug Development LetterSpecial ESMO 2024 edition !Copy linkFacebookEmailNotesMoreSpecial ESMO 2024 edition !Timothee Olivier and I discuss the top ESMO 2024 abstracts!Vinay Prasad and Timothée OlivierSep 14, 202411Share this postThe Drug Development LetterSpecial ESMO 2024 edition !Copy linkFacebookEmailNotesMoreShareTranscriptThe Drug Development Letter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.SubscribeDiscussion about this podcastCommentsRestacksShare this postThe Drug Development LetterSpecial ESMO 2024 edition !Copy linkFacebookEmailNotesMoreThe Drug Development LetterSubscribeAuthorsVinay PrasadTimothée OlivierRecent PostsRANDOMIZED versus REAL-WORLD EVIDENCE ON THE EFFICACY AND TOXICITY OF CHECKPOINT INHIBITORS.Dec 15 • Timothée OlivierSpecial post-ESMO 2024 edition !Nov 3 • Vinay Prasad and Timothée OlivierDriver mutation lung cancerSep 9 • Vinay PrasadSpecial post-ASCO 2024 edition !Jun 9 • Vinay Prasad and Timothée OlivierASCO pre-game showMay 30 • Vinay PrasadCAR T cells linked to secondary AML/MDSDec 24, 2023 • Vinay PrasadAsh Update with Aaron GoodmanDec 20, 2023 • Vinay Prasad and Aaron Goodman "Papa Heme"
Share this post